J. Christopher Naftzger

Insider Reports History

Entity
Individual
Location
633 Lowther Road, Lewisberry, PA
Signature
/s/ David C. Hastings as attorney-in-fact for J. Christopher Naftzger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by J. Christopher Naftzger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arbutus Biopharma Corp General Counsel and CCO Common Shares 95.1K $220K $2.31 Feb 1, 2024 Direct
Arbutus Biopharma Corp General Counsel and CCO Stock Option (Right to Buy) 381K Feb 1, 2024 Direct
Nabriva Therapeutics plc General Counsel and Corp Sec Stock Appreciation Right 63.2K Aug 11, 2022 Direct
Nabriva Therapeutics plc General Counsel and Corp Sec Phantom Shares 31.6K Aug 11, 2022 Direct
Nabriva Therapeutics plc General Counsel and Corp Sec Restricted Stock Units 0 Aug 11, 2022 Direct
Nabriva Therapeutics plc General Counsel and Corp Sec Share Options 0 Aug 11, 2022 Direct

Insider Reports Filed by J. Christopher Naftzger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABUS Arbutus Biopharma Corp Feb 1, 2024 2 $0 4 Feb 5, 2024 General Counsel and CCO
ABUS Arbutus Biopharma Corp Jul 10, 2023 1 $0 4 Jul 12, 2023 General Counsel and CCO
ABUS Arbutus Biopharma Corp Jul 10, 2023 0 $0 3 Jul 12, 2023 General Counsel and CCO
NBRV Nabriva Therapeutics plc Aug 11, 2022 4 $0 4 Aug 15, 2022 General Counsel and Corp Sec
NBRV Nabriva Therapeutics plc Dec 27, 2021 1 $4.13K 4 Dec 28, 2021 General Counsel and Corp Sec
NBRV Nabriva Therapeutics plc Sep 30, 2021 1 $0 4 Oct 1, 2021 General Counsel and Corp Sec
NBRV Nabriva Therapeutics plc Sep 3, 2021 0 $0 3 Sep 15, 2021 General Counsel and Corp Sec
NBRV Nabriva Therapeutics plc Jan 28, 2021 2 $0 4 Feb 1, 2022 General Counsel and Corp Sec